Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2 | 1 | 3 | 2 | 4 |
| Income taxes - deferred | 15 | N/A | N/A | N/A | N/A |
| Accounts receivable | 67 | -90 | 2 | 2 | 18 |
| Other Working Capital | -306 | 254 | 102 | 302 | 675 |
| Other Operating Activity | -1,000 | -814 | -1,488 | -1,246 | -1,558 |
| Operating Cash Flow | $-1,222 | $-649 | $-1,381 | $-940 | $-861 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 9 | 8 |
| Investing Cash Flow | $0 | $0 | $0 | $9 | $8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,655 | -114 | 100 | 2,699 | 0 |
| Other Financing Activity | 0 | 113 | 0 | 0 | 0 |
| Financing Cash Flow | $1,655 | $-1 | $100 | $2,699 | $0 |
| Beginning Cash Position | 65 | 715 | 1,996 | 228 | 1,081 |
| End Cash Position | 498 | 65 | 715 | 1,996 | 228 |
| Net Cash Flow | $433 | $-650 | $-1,281 | $1,768 | $-853 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,222 | -649 | -1,381 | -940 | -861 |
| Free Cash Flow | -1,222 | -649 | -1,381 | -940 | -861 |